Citations

Showing 10 of 108152 citations.

Ultrasound‐Guided Versus Landmark‐Based Approach to the Distal Suprascapular Nerve Block: A Comparative Cadaveric Study
Laumonerie, Pierre , Blasco, Laurent, Tibbo, Meagan E. , Kerezoudis, Panagiotis , Fernandes, Olivier, Lauwers, F. , Bonnevialle, Nicolas , Mansat, Pierre , Ohl, Xavier , Panagiotis, Kerezoudis, Laumonerie, Pierre

Mayo Clinic

Arthroscopy | July 23, 2019 | Volume: 35 | Issue: 8 | Pages: 2274-2281

10.1016/j.arthro.2019.02.050 | PMID 31350084 Get It

Purpose To compare the accuracy of distal suprascapular nerve (dSSN) blockade performed with the use of ultrasound‐guided regional anesthesia (USRA) versus with a landmark‐based approach (LBA). A secondary aim was to describe the anatomic features of the sensory branches of the dSSN. Methods USRA and LBA were performed in 15 shoulders each from 15 cadavers (total of 30 shoulders). Then, 10 mL of methylene blue‒infused ropivacaine 0.75% was injected into the dSSN. Simultaneously, 2.5 mL of red latex solution was injected to identify the position of the needle tip. The division and distribution of the sensory branches originating from the SSN were described. Results The tip of the needle was identified at 1.3 cm (range, 0‐5.2 cm) and 1.5 cm (range, 0‐4.5 cm) with USRA and the LBA, respectively ( P = .90). Staining diffused past the origin of the most proximal sensory branch in 27 cases. The most proximal sensory branch arose 2.5 cm from the suprascapular notch. Among the 3 failures that occurred in the USRA group, the sensory branches also failed to be marked. All 30 dSSNs gave off 3 sensory branches, which innervated the posterior glenohumeral capsule, the subacromial bursa, and the coracoclavicular and acromioclavicular ligaments. Conclusions An LBA is as reliable and accurate as US guidance for anesthetic blockade of the dSSN. Marking of the suprascapular nerve must be proximal to the suprascapular notch to involve the 3 sensory branches in the anesthetic blockade. Clinical Relevance The present study demonstrates that a landmark‐based approach to anesthetic blockade of the distal suprascapular nerve is accurate and can be performed by orthopaedic surgeons lacking experience in ultrasound‐guided anesthetic techniques.
Guidelines for neuromuscular ultrasound training
Tawfik, Eman A. , Cartwright, Michael S. , Grimm, Alexander , Boon, Andrea J. , Kerasnoudis, Antonios , Preston, David C. , Wilder‐Smith, Einar , Axer, Hubertus , Hobson‐Webb, Lisa D., Crump, Nicholas , Shahrizaila, Nortina , Inkpen, Peter, Mandeville, Ross , Sakamuri, Sarada, Shook, Steven J. , Shin, Susan , Walker, Francis O. , Crump, Nicholas , Shin, Susan , Alfen, Nens van

Mayo Clinic

Muscle & Nerve | July 23, 2019 | Volume: 60 | Issue: 4 | Pages: 361-366

10.1002/mus.26642 | PMID 31335971 Get It

AbstractNeuromuscular ultrasound has become an essential tool in the diagnostic evaluation of various neuromuscular disorders, and, as such, there is growing interest in neuromuscular ultrasound training. Effective training is critical in mastering this modality. Our aim was to develop consensus‐based guidelines for neuromuscular ultrasound training courses. A total of 18 experts participated. Expert opinion was sought through the Delphi method using 4 consecutive electronic surveys. A high degree of consensus was achieved with regard to the general structure of neuromuscular ultrasound training; the categorization of training into basic, intermediate, and advanced levels; the learning objectives; and the curriculum for each level. In this study, a group of neuromuscular ultrasound experts established consensus‐based guidelines for neuromuscular ultrasound training. These guidelines can be used in the development of the specialty and the standardization of neuromuscular ultrasound training courses and workshops.
Management of Depression in Women
Kransdorf, Lisa N. , Files, Julia A. , Kransdorf, Lisa N

Mayo Clinic

Journal of Women's Health | July 23, 2019 | Volume: 28 | Issue: 8 | Pages: 1019-1022

10.1089/jwh.2019.7908 | PMID 31335246 Get It

Two Cases of Rare Pancreatic Malignancies
Hanayneh, Wissam , Fitzpatrick, Garrett, Feely, Michael, George, Thomas J. , Starr, Jason S. , George, Thomas J , Parekh, Hiral D.

Mayo Clinic

Journal of Pancreatic Cancer | July 23, 2019 | Volume: 5 | Issue: 1 | Pages: 26-33

10.1089/pancan.2019.0007 | PMID 31338486 Get It

Ethical Tensions Resulting from Interpreter Involvement in the Consent Process
Barwise, Amelia , Hirsch, Jessica, Sharp, Richard, Barwise, Amelia K , Sharp, Richard R. , Hirsch, Jessica

Mayo Clinic

Ethics & Human Research | July 23, 2019 | Volume: 41 | Issue: 4 | Pages: 31-35

10.1002/eahr.500025 | PMID 31336041 Get It

ABSTRACTWe describe how our institution responded when an interpreter who participated in the consent process involving an individual with limited English proficiency refused to cosign consent documents attesting that the individual enrolling in the study understood the consent information and that her consent to enroll was voluntary. In developing our approach, our institution took into account ethical tensions between the Belmont principles of respect for persons, beneficence, and justice that apply to the protection of research participants and the professional principles of beneficence, fidelity, and respect for the importance of culture that are outlined in ethical guidelines for medical interpreters.
An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non–Small-Cell Lung Cancer
Norden, Andrew D., Henk, Henry J. , Mansfield, Aaron S. , Arunajadai, Srikesh, Carnahan, Ryan M. , Christian, Jennifer , Torres, Aracelis Z. , Mansfield, Aaron S , Stewart, Mark D. , Dreyer, Nancy A , Abernethy, Amy P. , Chrischilles, Elizabeth A. , Kushi, Lawrence H. , Khozin, Sean , Sharon, Elad , Miksad, Rebecca Anne , Sakoda, Lori C. , Valice, Emily , Allen, Jeff D.

Mayo Clinic

JCO Clinical Cancer Informatics | July 23, 2019 | Volume: No volume available | Issue: 3 | Pages: 1-15

10.1200/cci.18.00155 | PMID 31335166 Get It

PURPOSE This pilot study examined the ability to operationalize the collection of real-world data to explore the potential use of real-world end points extracted from data from diverse health care data organizations and to assess how these relate to similar end points in clinical trials for immunotherapy-treated advanced non–small-cell lung cancer. PATIENTS AND METHODS Researchers from six organizations followed a common protocol using data from administrative claims and electronic health records to assess real-world end points, including overall survival (rwOS), time to next treatment, time to treatment discontinuation (rwTTD), time to progression, and progression-free survival, among patients with advanced non–small-cell lung cancer treated with programmed death 1/programmed death-ligand 1 inhibitors in real-world settings. Data sets included from 269 to 6,924 patients who were treated between January 2011 and October 2017. Results from contributors were anonymized. RESULTS Correlations between real-world intermediate end points (rwTTD and time to next treatment) and rwOS were moderate to high (range, 0.6 to 0.9). rwTTD was the most consistent end points as treatment detail was available in all data sets. rwOS at 1 year post–programmed death-ligand 1 initiation ranged from 40% to 57%. In addition, rwOS as assessed via electronic health records and claims data fell within the range of median OS values observed in relevant clinical trials. Data sources had been used extensively for research with ongoing data curation to assure accuracy and practical completeness before the initiation of this research. CONCLUSION These findings demonstrate that real-world end points are generally consistent with each other and with outcomes observed in randomized clinical trials, which substantiates the potential validity of real-world data to support regulatory and payer decision making. Differences observed likely reflect true differences between real-world and protocol-driven practices.
Single-Dose Neoadjuvant AKT Pathway Inhibitor Reduces Growth of Hepatocellular Carcinoma after Laser Thermal Ablation in Small-Animal Model
Jondal, Danielle E. , Thompson, Scott M. , Butters, Kim A., Anderson, Jill , Roberts, Lewis R. , Callstrom, Matthew R. , Woodrum, David A. , Knudsen, Bruce E. , Anderson, Jill L, Callstrom, Matthew R , Roberts, Lewis R , Thompson, Scott

Mayo Clinic

Radiology | July 23, 2019 | Volume: 292 | Issue: 3 | Pages: 752-759

10.1148/radiol.2019190115 | PMID 31335281 Get It

Blood Biomarkers as Surrogate Endpoints of Treatment Responses to Aerobic Exercise and Cognitive Training (ACT) in Amnestic Mild Cognitive Impairment: The Blood Biomarkers Study Protocol of a Randomized Controlled Trial (The ACT Trial)
Bell, W Robert, Reilly, Cavan, Yu, Fang, Li, Danni , Mielke, Michelle M. , Zhang, Lin , Lin, Feng Vankee

Mayo Clinic

No container title available | July 23, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.2.11808/v1 Get It

Abstract Background: Alzheimer’s disease (AD) is an epidemic with tremendous public health impacts because there are currently no disease-modifying therapeutics. Randomized controlled trials (RCTs) for prevention of AD dementia often use clinical endpoints that take years to manifest (e.g., cognition) or surrogate endpoints that are costly or invasive (e.g., magnetic resonance imaging [MRI]). Blood biomarkers represent a clinically applicable alternative surrogate endpoint for RCTs that would be both cost-effective and minimally invasive, but little is known about their value as surrogate endpoints for treatment responses in the prevention of AD dementia. Methods: The objective of this study is to investigate blood neuropathological, neurodegenerative, and neurotrophic biomarkers as surrogate endpoints for treatment responses to 3 interventions in older adults with amnestic mild cognitive impairment (aMCI, a prodromal stage of AD): aerobic exercise; cognitive training; and combined aerobic exercise and cognitive training (ACT). We chose these three sets of biomarkers for their unique mechanistic associations with AD pathology, neurodegeneration and neurogenesis. This study is built on the ACT Trial (1R01AG055469), a single-blinded, multi-site, 2×2 factorial Phase II RCT that examines the synergistic effects of a 6-month ACT intervention on cognition and MRI biomarkers (AD-signature cortical thickness and hippocampal volume) (n=128). In this ACT Trial Blood Biomarkers Study, we will enroll 120 ACT Trial aMCI participants and measure blood biomarkers at baseline, 3, 6, 12 and 18 months. The goals are to: (1) Determine the effect of interventions on blood biomarkers over 6 months; (2) Evaluate blood biomarkers as surrogate endpoints for predicting cognitive responses to interventions over 18 months; and (3; exploratory) Examine blood biomarkers as surrogate endpoints for predicting brain MRI biomarker responses to interventions over 18 months. Discussion: This study aims to identify new blood biomarkers that can track cognitive decline or AD-related brain atrophy among aMCI patients subjected to a regimen of aerobic exercise and cognitive training. Findings from this study will drive the further use of blood biomarkers in developing effective prevention and treatment strategies for AD dementia. Trial registration number: This study is an ancillary study of the ACT Trial which was registered with ClinicalTrials.gov, NCT03313895.
In Our Own Words: A Qualitative Exploration of Complex Patient-Provider Interactions in an LGBTQ Population
Malik, Saba, Parker, Wendy M. , DeCoster, Barry, Master, Zubin , Campo‐Engelstein, Lisa

Mayo Clinic

Canadian Journal of Bioethics | July 23, 2019 | Volume: 2 | Issue: 2 | Pages: 83-93

10.7202/1062305ar Get It

While sexual and gender minorities are at increased risk for poor health outcomes, there is limited data regarding patient-provider interactions. In this study, we explored the perspectives of LGBTQ patients and their encounters with physicians in order to improve our understanding of patient-physician experiences. Using purposive selection of self-identified LGBTQ patients, we performed fourteen in-depth semi-structured interviews on topics of sexual orientation and gender identity, as well as their perceived role in the patient-provider relationship. Coding using a modified grounded theory approach was performed to generate themes. We identified three major themes that demonstrate the complexity of LGBTQ patient experiences. The first, Lacking trust, identifies mistrust and loss of the physician-patient relationship resulting from physicians’ poor or judgmental communication, or from physicians making assumptions about gender, using incorrect pronouns, and not recognizing heterogeneity within the transgender community. A second theme, Being vulnerable, describes the challenges and fears related to comfort of patients with disclosing their sexual orientation and/or gender identity. A final theme, Navigating discrimination, outlines racial or ethnic discrimination which creates an additional burden on top of illness and stigmatized identity. Our results reveal the complex needs of individuals with multiple stigmatized identities when developing relationships with providers. By using an intersectional perspective that appreciates the plurality of patients’ identities, providers can help to improve their relationships with LGBTQ patients. Incorporating intersectional training for medical students and residents could greatly benefit both LGBTQ patients and their physicians.
Prognostic Counseling for Patients With Idiopathic/Isolated REM Sleep Behavior Disorder: Should We Tell Them What's Coming? Yes
Louis, Erik K. St. , St Louis, Erik K, St Louis, E K

Mayo Clinic

Movement Disorders Clinical Practice | July 23, 2019 | Volume: 6 | Issue: 8 | Pages: 667-668

10.1002/mdc3.12814 | PMID 31745475 Get It